3 , bacterial species 25 typically evolve phage resistance by the mutation or loss of phage receptors under 26 laboratory conditions 4,5 . Here, we report how this discrepancy may in part be explained 27 by differences in the biotic complexity of in vitro and natural environments 6,7 . 28 Specifically, using the opportunistic pathogen Pseudomonas aeruginosa and its phage 29 DMS3vir, we show that coexistence with other human pathogens amplifies the fitness 30 trade-offs associated with phage receptor mutation, and therefore tips the balance in 31 favour of CRISPR-based resistance evolution. We also demonstrate that this has 32 important knock-on effects for P. aeruginosa virulence, which became attenuated only if 33 the bacteria evolved surface-based resistance. Our data reveal that the biotic complexity 34 of microbial communities in natural environments is an important driver of the 35 evolution of CRISPR-Cas adaptive immunity, with key implications for bacterial fitness 36 and virulence. 37
bacteria persisted due to the reduced size of the phage epidemic and hence relaxed selection 90 for resistance (Extended Data Fig. 3 ). Collectively, these data suggest that greater levels of 91 interspecific competition contribute to the evolution of CRISPR-based resistance. 92
Given that cell surface molecules likely play a part in interspecific competition 18 , we 93 hypothesised that the fitness cost of surface-based resistance may be amplified in the 94 presence of other bacterial species, resulting in stronger selection for bacteria with CRISPR-95 based resistance. To test this, we competed the two phage resistant phenotypes (i.e. CRISPR-96 resistant and surface mutant clones) in the presence or absence of the microbial community, 97
and across a range of phage titres. In the absence of the microbial community and phage, 98 CRISPR-resistant bacteria showed a small fitness advantage over bacteria with surface-based 99 resistance, but this advantage disappeared when phage was added and as titres increased ( the lowest levels of CRISPR (Fig. 1) . These fitness trade-offs therefore explain why P. 112 aeruginosa evolved greater levels of CRISPR-based resistance in the presence of the other 113 pathogens, and why this varied depending on the species (Fig. 1) . 114
Evolution of phage resistance by bacterial pathogens is often associated with 115 virulence trade-offs when surface structures are modified [19] [20] [21] , whereas similar trade-offs 116
have not yet been reported in the literature for CRISPR-based resistance. We therefore 117 hypothesised that the community context in which phage resistance evolves may have 118 important knock-on effects for P. aeruginosa virulence. To test this, we used a Galleria 119 mellonella larvae infection model, which is commonly used to evaluate the virulence of 120 human pathogens 22, 23 . We compared in vivo virulence of P. aeruginosa clones that evolved 121 phage resistance in different community contexts by injecting larvae with a mixture of clones 122 that had evolved phage-resistance in either the presence or absence of the mixed bacterial 123 community (Extended Data. Fig. 2 ). Taking time to death as a proxy for virulence, we found 124 that the evolution of phage resistance in the presence of a microbial community was 125 associated with greater levels of P. aeruginosa virulence compared to when phage-resistance 126 evolved in monoculture, and similar to that of the ancestral PA14 strain ( Collectively, our data show that the evolutionary outcome of bacteria-phage 143 interactions can be fundamentally altered by the microbial community context. While 144 traditionally studied in isolation, these interactions are usually embedded in complex biotic 145 networks of multiple species, and it is becoming increasingly clear that this can have key 146 implications for the evolutionary epidemiology of infectious disease, including the evolution 147 of pathogen virulence and host range [25] [26] [27] [28] [29] . The work presented here reveals that the 148 community context can also shape the evolution of different host resistance strategies. 149
Specifically, we find that the interspecific interactions between four bacterial species in a 150 synthetic microbial community can have a large impact on the evolution of phage resistance 151 mechanisms by amplifying the constitutive fitness cost of surface-based resistance 4 . The 152 finding that biotic complexity matters complements previous work on the effect of abiotic 153 variables on phage resistance evolution. This previous work showed that a greater force of 154 infection resulted in a higher induced fitness cost of CRISPR-based resistance, hence 155 selecting for surface-based resistance in the presence of higher phage titres 4 . Variation in the 156 force of infection did not however seem to play a role in the effects described in this study, 157 since even though phage epidemic sizes varied depending on the microbial community 158 composition (Extended Data Fig. 4 , ANOVA: Overall effect of P. aeruginosa starting 159 percentage on phage titre; F6,105 = 14.84, p < 0.001), they did not correlate with the levels of 160 evolved CRISPR-based resistance (Extended Data Fig. 5 ). This therefore suggests that in this 161 case the impact of biotic complexity on the evolution of CRISPR-based resistance is stronger 162 than that of variation in phage abundance. While future work will be critical to further 163 generalise the findings described here to other bacterial species and strains, we speculate that 164 the way in which the microbial community composition drives the evolution of phage 165 resistance strategies may be important in the context of phage therapy. Primarily, the absence 166 of detectable trade-offs between CRISPR-based resistance and virulence, as opposed to when 167 bacteria evolve surface-based resistance, suggests that evolution of CRISPR-based resistance 168 can ultimately influence the severity of disease. Moreover, evolution of CRISPR-based 169 resistance can drive more rapid phage extinction 30 , and may in a multi-phage environment 170 result in altered patterns of cross-resistance evolution compared to surface-based resistance 31 . 171
The identification of the drivers and consequences of CRISPR-resistance evolution might 172 help to improve our ability to predict and manipulate the outcome of bacteria-phage 173 interactions in both natural and clinical settings. 
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